We are involved in the development of "Non-Modular" Branched
Endograft Technology for the treatment of Aortic Aneurysms of the Thoracic and Abdominal Aorta.
The minimally invasive treatment of Aortic aneurysms with Endoluminal graft technology has become the "Gold Standard" for treatment of this disease. The unique Intellectual Property based on my patents and patent applications will allow us to bring this technology to the next level which no other company can duplicate. Our "One Piece" technology will allow our company to be the "Gold Standard" for these devices.
Team
James Hill, MD, JD
Member
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.